Skip to main navigation Skip to search Skip to main content

CYP2C19*2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment

  • K. Beelen
  • , M. Opdam
  • , T. M. Severson
  • , R. H.T. Koornstra
  • , A. D. Vincent
  • , M. Hauptmann
  • , R. H.N. Van Schaik
  • , E. M.J.J. Berns
  • , J. B. Vermorken
  • , P. J. Van Diest
  • , S. C. Linn

Research output: Contribution to journal › Article › peer-review

23   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'CYP2C19*2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science